NR3C1 and lung cancer: The cellular response of lung cancer patients to OxS is related to many metabolic pathways/genes of antioxidant enzymes, and these enzymes include superoxide dismutase, glutathione peroxidase, glucocorticoid receptor, heme oxygenase, and hypoxia inducible factor-1 genes α [34].